Company / Cash per Share
Denali Therapeutics Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.42
FY2025
5-year range
$0.93 / $2.43
FY2021-FY2025
Trend
+12.6%
vs FY2024
Sector context
#129 of 205
Health Care
What the data says
At $1.42, Denali Therapeutics Inc.'s cash per share ranks #129 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $0.81 in FY2019 to $14.59 in FY2017.
Based on SEC 10-K filings.
1.42 in FY2025 with a 5-year CAGR of -23.0%.
Improved from $0.93 to $1.42 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -7.2%
- 5-Year CAGR
- -23.0%
- 10-Year CAGR
- -
Sector benchmark
#129 of 205 in Health CareTop 63% of 205This company $1.42 Sector average $67.98
▼
-97.9% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 12.6% year-over-year.
- Ranks #129 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2017.
- Lowest cash per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.73 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.42 | +12.6% |
| FY2024 | $1.26 | +35.2% |
| FY2023 | $0.93 | -47.6% |
| FY2022 | $1.78 | -26.8% |
| FY2021 | $2.43 | -53.8% |
| FY2020 | $5.27 | +547.1% |
| FY2019 | $0.81 | -67.4% |
| FY2018 | $2.50 | -82.9% |
| FY2017 | $14.59 | +135.3% |
| FY2016 | $6.20 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026